That is necessary, since the way a protein in the human body folds determines if a pharmaceutical will have the ability to bind to that protein and be reliable. In other words, we need to know how these proteins fold if we want a drug to work. Historically, this has actually been a trial-and-error process (self-driving cars). And now, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it much simpler to produce drugs that do what they're designed to do. This was a breakthrough practically nobody saw. However it's going to have profound implications for curing illness. I forecast that Alpha, Fold will be 98% precise by the end of 2021.
And, obviously, there will be lots of financial investment opportunities in this area, too. Moving subjects It's going to be an excellent year for bitcoin. I'm bullish on it in 2021 (angel investor). That stated, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I would not be shocked if it drew back possibly considerably before going greater - jeff brown 1 biotech company. I've been covering bitcoin for a long period of time now. One of the very first research study reports I ever published was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that initial recommendation, I titled my report "What's the Big Offer With Bitcoin?" That shows you where the conversation was at the time. We were mainly informing readers. However that's not the big concern any longer. Now we're seeing institutional cash lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, specific niche enterprise. Mass, Mutual is a relied on 170-year-old organization. So think of that. In 5 years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
Which's a huge factor I'm bullish on it this year. angel investor. Regards, Jeff Brown, Editor, The Bleeding Edge I have a benefit forecast 2020 was a record year for IPOs. 552 U.S. business went public the most in more than 20 years. These business raised an overall of $172 billion. That's an all-time high beating the previous annual record by 43%. I predict 2021 will be another record year in IPOs. There are a lot of fantastic personal companies on the edge of hitting the public markets And I have actually been dealing with a brand-new way for you to invest even prior to these business go public.
This chance has been constructing over the last couple of years. I can't wait to tell you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to discover all the details. Go right here to book your spot free of charge.
Emma Walsh here, managing editor of the Journal. Routine Journal readers understand that tech isn't our usual beat (jeff brown biotech stock). And when it concerns tech investing, we leave it to the experts. Luckily, we have several such experts in our Rolodex. Our coworker Jeff Brown will be familiar to our long time readers. He is among the most accomplished tech investing professionals we understand (jeff brown). In truth, he had several triple-digit returns in his Brownstone Research portfolios last year. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to have a look at the huge picture and anticipate what's just around the corner.
That includes things like 5G networks, biotech, artificial intelligence, and a lot more. These patterns are experiencing exponential growth and developing extraordinary opportunities for investors. I desire to ensure all our readers are prepared for what's next. And with that in mind, let me draw the photo of what I see being available in the next 12 months Our brand-new 5G (fifth-generation) cordless networks are a subject I've been covering for years now. bleeding edge. But in spite of what numerous readers may believe, this is a trend that's just getting begun. Despite the fact that the COVID-19 pandemic disrupted supply chains last year, a remarkable 250 million 5G-enabled gadgets were still offered.
And all of this eventually resulted in Apple delaying the release of the 5G-enabled i, Phone 12 by 2 months (jeff brown market predictions). Losing two months of production and sales actually impacts how lots of 5G gadgets are offered in the calendar year. When you consider all of that, selling 250 million units is exceptional. More notably, the delays triggered by the pandemic created a lots of bottled-up demand. And that demand is now going to be pushed into 2021. In reality, I forecast that more than 500 million 5G gadgets will be delivered in 2021 - first lady. Which's not my only 5G forecast When I have actually talked about 5G in the past, I have actually explained its 3 various phases.
In Stage Two, 5G gadgets go on sale. 5G phones and other products begin to reach consumers. And in Stage Three, 5G services start to be offered (brownstone research stock). That's when we begin to see applications running on 5G networks. Believe of things like massive multiplayer games over a cellphone. That's not possible with 4G. It will be with 5G. And my 2nd 5G forecast for 2021 is that we will start Stage 3 by this summertime. This begins something of a virtuous cycle: Many people don't really care about the technology. But they will care if there are exciting applications that can only be accessed with a 5G phone.
That leads to more 5G apps being established. In fact, 5G is going to open up a suite of amazing applications: self-driving automobiles, the Web of Things, robotic surgical treatment, and more. All of these innovations need 5G. The investment opportunities going forward will be huge. Stepping away from 5G, the next crucial innovation I visualize in 2021 is CRISPR hereditary editing. CRISPR represents "clustered regularly interspaced short palindromic repeat." It's a mouthful. But it's one of the most exciting developments in biotechnology. At a high level, CRISPR is a technology that can modify our hereditary makeup as if it were software application.
The program can crash or not operate correctly. CRISPR utilizes a similar idea but with our genetic code. "Typos" in our genome can lead to illness. CRISPR can fix these "typos." For many years, CRISPR was mostly a niche technology that wasn't well understood. And during that time, there were actually just three business running in this area. However things are altering. CRISPR is no longer just theoretical. We're seeing real outcomes. We're treating diseases and seeing that this technology just works. And as a result, a "2nd crop" of early-stage CRISPR business is going public and providing amazing returns. This whole market is successfully a greenfield opportunity.
There's space for lots of business to exist in this area. diplomatic relations. And there will be more. That's my prediction for CRISPR in 2021. I forecast that two or 3 more genetic modifying companies will hold their IPOs. Sticking with biotechnology, we are seeing fantastic things taking place at the convergence of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, simply revealed at the end of 2020 that its newest Alpha, Fold software application can precisely anticipate the folding of a protein based solely on its amino acid sequence with 92. 4% accuracy. That's important since the method a protein in the human body folds figures out if a pharmaceutical will be able to bind to that protein and work.
Historically, this has been a trial-and-error procedure. Today, Alpha, Fold can anticipate protein folding with 92. 4% accuracy. That's going to make it a lot easier to produce drugs that do what they're developed to do. And here's my next forecast. I predict that Alpha, Fold will be 98% precise by the end of 2021. And we will see not just one however numerous drug treatments produced utilizing this innovation. This was among those developments that practically no one observed. However it's going to have extensive ramifications for curing disease. And, of course, there will be a lot of investment chances in this area, too.
It's going to be a great year for bitcoin. I'm bullish on it in 2021. That stated, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be shocked if it pulled back perhaps significantly before going higher. I have actually been covering bitcoin for a very long time now. One of the first research reports I ever released was on bitcoin - future report review. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for any person who followed my suggestion. But at the time of that initial suggestion, I entitled my report, "What's the Big Offer With Bitcoin?" That reveals you where the discussion was at the time.
However no one is asking that concern anymore. Now, we're seeing institutional money lastly taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, specific niche business. jeff brown prediction for 2021. Mass, Mutual is a 150-year-old organization. So consider that. In 5 years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a huge reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another reward forecast In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown deserves about $27. 5 million and claims the information is up to date as of February 2021, but we might not separately verify this claim. Provided Jeff Brown's past, he likely has a substantial net worth, but we can't hammer down an accurate figure at this moment. Brown is best understood for his sage-like capability to pick winning technology stocks. He invested more than 25 years researching technology business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's extensive experience gives him an excellent viewpoint on the marketplace. He's always on the hunt for new chances, and he shares a number of his best choices in the Near Future Report.
That's full marks, however it's not absurdly reasoned. Brown has an exceptional reputation as a stock-picker, and he effectively anticipated some of the biggest economic occasions of the past twenty years. Although he does not appear to launch his choices to the public, the service's success is a direct indication of Brown's stock-picking expertise. No one on Wall Street gets it right each time, however Jeff Brown's accurate predictions have earned him legions of devoted fans. That says a lot about his ability. The Future Report is released by Brownstone Research, a popular financial research study publisher. Brownstone Research offers a number of research services with a variety of expertises - the legacy report predictions.
The business is likewise affiliated with Bonner & Partners, another well-respected research study publisher - last week. On its site, Brownstone states its mission is to supply retail investors with professional-grade research study: "For too long, the finest investment research study has not been readily available to private investors. It has been typically reserved for investment banks, hedge funds, personal equity, and high-net-worth clients. tech stocks. The mission of Brownstone Research is to make that sort of proprietary research study available to any financiers seeking to gain an edge in the markets. The goal is easy to deliver unique and successful financial investment research discovered nowhere else." -Brownstone Research study website excerpt from the Jeff Brown is the creator of Brownstone Research study, and he likewise serves as the company's Chief Investment Expert.
With Brown guiding the ship, Brownstone Research study is a powerhouse publisher with lots to use its customers. After decades of stable success at the helm of top-tier business like Tesla and Area, X, Elon Musk is a household name throughout the majority of America. If you understand even a bit about the market, you know that he has a track record as a King Midas of sorts. jeff brown prediction for 2021. Whatever he touches turns to gold! Jeff is aware of Elon Musk's executive expertise, so he always has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next big project.
In truth, Brown believes S.A.V. jeff brown 2020 predictions. might be "the most significant pattern of the 2020s, and he's not alone. Have a look at these quotes from other popular S.A.V. bulls: Elon's next huge act will be weding two advanced technologies: artificial intelligence and electric automobiles. Musk hopes the mix will help him establish the first fully-autonomous, self-driving vehicles ever. It's absolutely nothing except the automotive market's Holy Grail. As you understand, electric cars and self-driving car stocks have been big this year, but the Wall Street machine has been huge on buzz without much tangible result. Despite an extreme increase in competition over the previous couple of years, Brown still thinks Musk has the finest opportunity of putting it all together.
tech might be the magic string that ties everything together. S.A.V. stands for Shared Autonomous Car, and it might be the future of transport. Essentially, this innovation would allow you to rent out your automobile as an autonomous, self-driving taxi when you're not using it. You just get out of the cars and truck and press a button on an app that tells the cars and truck to "join the fleet." Next thing you know, you're relaxing on your couch while your vehicle shuttles ride-sharers around town. Best of all, you get to keep a significant piece of the revenues. It sounds insane, but it could be closed than you believe.